CLINICAL UTILITY OF IMMUNOHISTOCHEMISTRY FOR THE DETECTION OF THE BRAF V600E MUTATION IN PAPILLARY THYROID CARCINOMA

BACKGROUND: BRAF V600E mutation is the most common genetic alteration in papillary thyroid cancer (PTC). We utilized a mutation-specific antibody for immunohistochemical (IHC) detection of the BRAF V600E mutation and correlated expression with clinicopathological features. The study was designed to...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zagzag, Jonathan, Pollack, Aron, Dultz, Linda, Dhar, Shumon, Ogilvie, Jennifer B., Heller, Keith S., Deng, Fang-Ming, Patel, Kepal N.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2013
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4100700/
https://ncbi.nlm.nih.gov/pubmed/23931769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.surg.2013.06.020
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares